// App-Quantinova.ai

Filters

Biomarkers

No records found for your search

Conference Name

No records found for your search

Country

























Company

Search valid company name..

Conference Year













Drug











Disease

Medical Centers

Search valid medical center name..

Outcomes





Presenter

Search valid presenter name..

Principal Investigators

Search valid principal investigator name..

Phase










Patient Segments

Search valid patient segment..

Result



Sponsor

Search valid sponsor name..

Study ID

Search your valid Study ID..

Therapeutic Area
























28841 Abstracts

BiologicalMarkers of Social and Emotional Impairment after TraumaticBrain Injury.

M.H. BEAUCHAMP - International Neuropsychological Society (INS) , 2015

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Executive dysfunction

N/A

Theory of Mind and Emotional FaceProcessing after Early Mild Traumatic Brain Injury.

J. BELLEROSE - International Neuropsychological Society (INS) , 2015

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Traumatic brain injury

N/A

Investigating Attentionand Executive Functions Impact on Intraindividual Variability inChildren with Fetal Alcohol Spectrum Disorder (FASD).

K.A. KERNS - International Neuropsychological Society (INS) , 2015

Therapeutic Area

Disease

Drug/Treatment

Obstetrics/Gynecology

Female Sexual Dysfunction

N/A

Complex Neurodevelopmental Profile, Reminiscentof Williams Syndrome, in a Child with EP300-related SyndromicIntellectual Disability.

J.S. PARBOOSINGH - International Neuropsychological Society (INS) , 2015

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Williams beuren syndrome

EP300

AnAlzheimers Genetic Risk Composite Interacts with DiabetesStatus to Predict Neurocognitive Speed Level and Change in NonDementedOlder Adults.

S.A. WIEBE - International Neuropsychological Society (INS) , 2015

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Perceived Parental Support and SocialStress as Moderators of Cognitive Decline in Pediatric-OnsetMultiple Sclerosis Patients.

B. HOSSEINI - International Neuropsychological Society (INS) , 2015

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Effectsof Cannabis Use on Gray Matter Volume and Cognition in Patientswith Multiple Sclerosis.

B. PAVISIAN - International Neuropsychological Society (INS) , 2015

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Multiple Sclerosis

N/A

Copy-number Variation in Canadian Childrenwith Developmental Coordination Disorder ImplicatesNeurodevelopmental Genes.

S.J. MOSCA - International Neuropsychological Society (INS) , 2015

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

DevelopmentalMotor Disorders: From Genes to Brains to Behavior.

P.J. ANDERSON - International Neuropsychological Society (INS) , 2015

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Attention deficit hyperactivity disorder

N/A

Executive Function Deficitsin Children with Developmental Coordination Disorder andAttention Deficit Hyperactivity Disorder: Same or Different.

D. DEWEY - International Neuropsychological Society (INS) , 2015

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Attention deficit hyperactivity disorder

N/A

FunctionalBrain Activation during a Motor Inhibition Task in Children withDevelopmental Coordination Disorder and Attention Deficit/Hyperactivity Disorder.

S.BRAY - International Neuropsychological Society (INS) , 2015

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Attention deficit hyperactivity disorder

N/A

Developmental Brain Dysfunction:Co-occurrence is Associated with Impaired NeuropsychologicalFunctioning.

L. LANGEVIN - International Neuropsychological Society (INS) , 2015

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Attention deficit hyperactivity disorder

N/A

Children with Benign Epilepsywith Centro-temporal Spikes: an fMRI, Cognitive and BehavioralStudy.

A. TUCHOLKA - International Neuropsychological Society (INS) , 2015

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Self-awareness of Patients on a Neuropsychiatric Unit.

Rosa Ip - International Neuropsychological Society (INS) , 2015

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Methodological Guidelines to Improve Research Designs onCognition in Schizophrenia.

M. ROY - International Neuropsychological Society (INS) , 2015

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Schizophrenia

N/A

The effect ofMaltreatment on Neuropsychological functioning of Children,Adolescents and Adults with Psychiatric disorders: Meta-analysis.

M. MASSON - International Neuropsychological Society (INS) , 2015

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Disconnexion Syndromes and Aphasia.

Andrew Kertesz - International Neuropsychological Society (INS) , 2015

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Exercise training alters functional connectivity in children treatedfor posterior fossa brain tumors.

S. GAUVREAU - International Neuropsychological Society (INS) , 2015

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Brain cancer

N/A

The Role of Physiological Factors and Novel Interventions inMitigating Poor Neuropsychological Outcomes in Pediatric BrainTumor Survivors.

L.M. JACOLA - International Neuropsychological Society (INS) , 2015

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Craniopharyngioma

N/A

Predicting Attention Problems in the First Year FollowingPediatric Traumatic Brain Injury (TBI).

N. SIMIC - International Neuropsychological Society (INS) , 2015

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Traumatic brain injury

N/A

Copyright © 2026. QuantiNova All rights reserved